More Guidelines than states: variations in U.S. lead screening and management guidance and impacts on shareable CDS development.

Year of Publication


Number of Pages


Date Published

2020 Jan 29

ISSN Number



<p><strong>BACKGROUND: </strong>Pediatric lead exposure in the United States (U.S.) remains a preventable public health crisis. Shareable electronic clinical decision support (CDS) could improve lead screening and management. However, discrepancies between federal, state and local recommendations could present significant challenges for implementation.</p>

<p><strong>METHODS: </strong>We identified publically available guidance on lead screening and management. We extracted definitions for elevated lead and recommendations for screening, follow-up, reporting, and management. We compared thresholds and level of obligation for management actions. Finally, we assessed the feasibility of development of shareable CDS.</p>

<p><strong>RESULTS: </strong>We identified 54 guidance sources. States offered different definitions of elevated lead, and recommendations for screening, reporting, follow-up and management. Only 37 of 48 states providing guidance used the Center for Disease Control (CDC) definition for elevated lead. There were 17 distinct management actions. Guidance sources indicated an average of 5.5 management actions, but offered different criteria and levels of obligation for these actions. Despite differences, the recommendations were well-structured, actionable, and encodable, indicating shareable CDS is feasible.</p>

<p><strong>CONCLUSION: </strong>Current variability across guidance poses challenges for clinicians. Developing shareable CDS is feasible and could improve pediatric lead screening and management. Shareable CDS would need to account for local variability in guidance.</p>



Alternate Title

BMC Public Health




Subscription is not available for this page.